148 related articles for article (PubMed ID: 31118490)
1. 'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration.
Taylor DJ; Jones L; Binns AM; Crabb DP
Eye (Lond); 2020 Mar; 34(3):461-473. PubMed ID: 31118490
[TBL] [Abstract][Full Text] [Related]
2. Seeing it differently: self-reported description of vision loss in dry age-related macular degeneration.
Taylor DJ; Edwards LA; Binns AM; Crabb DP
Ophthalmic Physiol Opt; 2018 Jan; 38(1):98-105. PubMed ID: 29168192
[TBL] [Abstract][Full Text] [Related]
3. Comment on: 'You've got dry macular degeneration, end of story: a qualitative study into the experience of living with non-neovascular age-related macular degeneration'.
Gandhi JS
Eye (Lond); 2020 Oct; 34(10):1935-1936. PubMed ID: 31836833
[No Abstract] [Full Text] [Related]
4. The effect of non-neovascular age-related macular degeneration on face recognition performance.
Taylor DJ; Smith ND; Binns AM; Crabb DP
Graefes Arch Clin Exp Ophthalmol; 2018 Apr; 256(4):815-821. PubMed ID: 29484559
[TBL] [Abstract][Full Text] [Related]
5. Ten-year follow-up of age-related macular degeneration in the age-related eye disease study: AREDS report no. 36.
Chew EY; Clemons TE; Agrón E; Sperduto RD; Sangiovanni JP; Davis MD; Ferris FL;
JAMA Ophthalmol; 2014 Mar; 132(3):272-7. PubMed ID: 24385141
[TBL] [Abstract][Full Text] [Related]
6. Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study.
Bellmann C; Unnebrink K; Rubin GS; Miller D; Holz FG
Graefes Arch Clin Exp Ophthalmol; 2003 Dec; 241(12):968-74. PubMed ID: 13680248
[TBL] [Abstract][Full Text] [Related]
7. Response to 'Comment on: 'You have got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration'.
Taylor DJ; Jones L; Binns AM; Crabb DP
Eye (Lond); 2020 Oct; 34(10):1937-1938. PubMed ID: 31836834
[No Abstract] [Full Text] [Related]
8. Phase 1 Clinical Trial of Elamipretide in Dry Age-Related Macular Degeneration and Noncentral Geographic Atrophy: ReCLAIM NCGA Study.
Mettu PS; Allingham MJ; Cousins SW
Ophthalmol Sci; 2022 Mar; 2(1):100086. PubMed ID: 36246181
[TBL] [Abstract][Full Text] [Related]
9. Impact of visual function on computer task accuracy and reaction time in a cohort of patients with age-related macular degeneration.
Scott IU; Feuer WJ; Jacko JA
Am J Ophthalmol; 2002 Mar; 133(3):350-7. PubMed ID: 11860972
[TBL] [Abstract][Full Text] [Related]
10. [Long-term results in neovascular age-related macular degeneration : Changes in visual acuity and geographic atrophy during long-standing anti-VEGF therapy].
Thalgott V; Feucht N; Lohmann CP; Maier M
Ophthalmologe; 2016 Aug; 113(8):668-74. PubMed ID: 26920612
[TBL] [Abstract][Full Text] [Related]
11. Mesopic Pelli-Robson contrast sensitivity and MP-1 microperimetry in healthy ageing and age-related macular degeneration.
Maynard ML; Zele AJ; Feigl B
Acta Ophthalmol; 2016 Dec; 94(8):e772-e778. PubMed ID: 27225020
[TBL] [Abstract][Full Text] [Related]
12. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.
Sunness JS; Rubin GS; Broman A; Applegate CA; Bressler NM; Hawkins BS
Ophthalmology; 2008 Sep; 115(9):1480-8, 1488.e1-2. PubMed ID: 18486216
[TBL] [Abstract][Full Text] [Related]
13. Patient selection criteria for pilot studies on amelioration of non-neovascular age-related macular degeneration.
Azuma M; Chung K; Fujii A; Shearer TR
J Ocul Pharmacol Ther; 2010 Aug; 26(4):367-71. PubMed ID: 20653480
[TBL] [Abstract][Full Text] [Related]
14. Visual Function Metrics in Early and Intermediate Dry Age-related Macular Degeneration for Use as Clinical Trial Endpoints.
Cocce KJ; Stinnett SS; Luhmann UFO; Vajzovic L; Horne A; Schuman SG; Toth CA; Cousins SW; Lad EM
Am J Ophthalmol; 2018 May; 189():127-138. PubMed ID: 29477964
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study.
Banister K; Cook JA; Scotland G; Azuara-Blanco A; Goulão B; Heimann H; Hernández R; Hogg R; Kennedy C; Sivaprasad S; Ramsay C; Chakravarthy U
Health Technol Assess; 2022 Jan; 26(8):1-142. PubMed ID: 35119357
[TBL] [Abstract][Full Text] [Related]
16. Correction: 'You've got dry macular degeneration, end of story': a qualitative study into the experience of living with non-neovascular age-related macular degeneration.
Taylor DJ; Jones L; Binns AM; Crabb DP
Eye (Lond); 2020 Mar; 34(3):603. PubMed ID: 31488885
[TBL] [Abstract][Full Text] [Related]
17. Macular function impairment in eyes with early age-related macular degeneration.
Midena E; Degli Angeli C; Blarzino MC; Valenti M; Segato T
Invest Ophthalmol Vis Sci; 1997 Feb; 38(2):469-77. PubMed ID: 9040480
[TBL] [Abstract][Full Text] [Related]
18. Mental health and visual acuity in patients with age-related macular degeneration.
Fonteh CN; Mathias MT; Mandava N; Manoharan N; Lynch AM; Navo R; Patnaik JL;
BMC Ophthalmol; 2022 Oct; 22(1):391. PubMed ID: 36183081
[TBL] [Abstract][Full Text] [Related]
19. Association between Patient-Reported Outcomes and Time to Late Age-Related Macular Degeneration in the Laser Intervention in Early Stages of Age-Related Macular Degeneration Study.
McGuinness MB; Finger RP; Wu Z; Luu CD; Chen FK; Arnold JJ; Chakravarthy U; Guymer RH;
Ophthalmol Retina; 2020 Sep; 4(9):881-888. PubMed ID: 32418845
[TBL] [Abstract][Full Text] [Related]
20. Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration.
Evans JR; Lawrenson JG
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD000254. PubMed ID: 28756618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
